Heart Failure: Will There be Any light at the End of the Tunnel with Stem Cell Therapy?
DOI:
https://doi.org/10.2015/hc.v5i1%20Sup.232Abstract
Cardiac regeneration using stem cells emerges as a noveltreatment option for heart failure. Clinical applications have
reported encouraging but modest favorable results, concerning
cardiac functional recovery. However, many issues need clarification.
The most appropriate cell type, the optimal number of
injected cells and time for cell delivery, as well as the mode of
cell function remain to be elucidated. Furthermore, ways to improve cell survival and long term engraftment are being sought, in an effort to enhance the regenerative capability of the cells. A substantial amount of basic, translational and clinical research is still needed, in order to take advantage of the full therapeutic
potential of stem cell treatments for heart failure.
Downloads
Issue
Section
License
Authors who publish with this journal agree to the following terms:a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
